Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Prognostic value of P53 codon 72 polymorphism in invasive cervical cancer in Brazil
Author: Brenna, SMF
Silva, IDCG
Zeferino, LC
Pereira, JS
Martinez, EZ
Syrjanen, KJ
Abstract: Objective. The prognostic value of p53 codon72 polymorphism was analyzed in Brazilian women with cervical cancer. Methods. The present study consists of 148 women diagnosed and treated for invasive cervical carcinoma (FIGO stages Ib-IIIb) between 1992 and 2002, Demonstration of p53 polymorphism was performed in DNA extracted from paraffin-embedded sections using the polymerase chain reaction (PCR). Results. Among the 148 women, arg/arg was found in 99 (67%) and, arg/pro in 49 (33%). The overall survival (OS) curves (univariate) were different between arg/arg and arg/pro patients (P = 0.01). There was slightly increased risk of death for arg/arg patients (crude HR 2.2 CI 95% 1.2-4.0), which was not confounded by FIGO stages (adjusted FIR 2.4 CI 95% 1.3-4.3). For disease-free survival (DFS), two situations were considered: (1) 124 women who received any treatment, and (2) 118 who received FIGO-recommended treatment. In the first group, 59% of arg/arg patients presented recurrence as compared to 32% in the arg/pro group (P = 0.02), whereas in the second group, 61% of the arg/arg and 34% arg/pro showed recurrence (P = 0.04). The risk of recurrence adjusted by FIGO stage for the 124 patients was 2.4 (CI 95% 1.0-3.7) and for the 118 it was 1.9 (CI 95% 1.0-3.4). These adjusted models showed no confounding and no interaction. Conclusions. Despite the prognostic significance of p53 polymorphism in univariate survival analysis, there was no or only marginal evidence on the independent prognostic value of p53arg/arg in multivariate analysis. The more ominous prognosis of the homozygous (arg/ arg) patients was explained by the primary treatment, independent on the FIGO stage. (C) 2004 Elsevier Inc. All rights reserved.
Subject: p53 polymorphism
codon 72
cervical cancer
human papillomavirus (HPV)
Country: EUA
Editor: Academic Press Inc Elsevier Science
Citation: Gynecologic Oncology. Academic Press Inc Elsevier Science, v. 93, n. 2, n. 374, n. 380, 2004.
Rights: fechado
Identifier DOI: 10.1016/j.ygyno.2004.03.004
Date Issue: 2004
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000221120500016.pdf232.16 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.